This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
artificial-intelligence: Archive
NNN REIT (NNN) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
NNNNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Okta (OKTA) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
OKTANegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
C4 Therapeutics, Inc. (CCCC)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
CCCCNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
After Golden Cross, Ultragenyx (RARE)'s Technical Outlook is Bright
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
RAREPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Juniper to Be Bought by HPE; Fake News on Bitcoin ETFs
by Mark Vickery
This is a long-awaited development for the fledgling asset class, one which may welcome new investors into the crypto fold.
NVDANegative Net Change KBHPositive Net Change HPENegative Net Change
artificial-intelligence bitcoin etfs
Ceridian (CDAY) Boosts Retail Sector With Dayforce Innovation
by Zacks Equity Research
Ceridian HCM (CDAY) transforms retail workforce management with Dayforce's AI forecasting and flexible shift marketplace.
MSFTNegative Net Change CAMTNegative Net Change CDAYPositive Net Change DASHPositive Net Change
artificial-intelligence tech-stocks
Carrier (CARR) Expands Portfolio With Montana Partnership
by Zacks Equity Research
Carrier Global (CARR) invests $10M in Montana's AirJoule tech, transforming cooling technology and reducing carbon emissions.
HONNegative Net Change CAMTNegative Net Change CARRNegative Net Change DASHPositive Net Change
artificial-intelligence tech-stocks
Amdocs (DOX) Introduces Next-Generation CPQ Pro for CSPs
by Zacks Equity Research
Amdocs (DOX) introduces its next-generation configure-price-quote software, Amdocs CPQ Pro, supported by amAlz AI for CSPs.
DOXNegative Net Change BZPositive Net Change EVBGPositive Net Change CDAYPositive Net Change
artificial-intelligence automation saas tech-stocks
Ambarella (AMBA) Brings AI to Endpoint Devices Via N1 SoCs
by Zacks Equity Research
Ambarella (AMBA) brings generative artificial intelligence to edge endpoint devices and on-premise hardware through the N1 SoCs Series.
BZPositive Net Change AMBANegative Net Change EVBGPositive Net Change CDAYPositive Net Change
artificial-intelligence automation computers semiconductor tech-stocks
Juniper (JNPR) Reportedly to be Acquired by HP Enterprise
by Zacks Equity Research
Juniper (JNPR) is in advance talks to be acquired by Hewlett Packard Enterprise for $13 billion. The potential buyout will significantly boost HPE's AI offerings and bolster its competitive edge in the industry.
NVDANegative Net Change WDAYNegative Net Change HPENegative Net Change
artificial-intelligence tech-stocks
What Does CES 2024's Automotive Tech Spectacle Have in Store?
by Rimmi Singhi
Dive into the electrifying world of CES 2024 where Honda, Kia, Hyundai, BMW, Mercedes and Volkswagen unveil groundbreaking EVs and AI innovations, thus reshaping the future of automotive technology.
HMCPositive Net Change VWAGYNegative Net Change
artificial-intelligence auto-tires-trucks electric-vehicles
Bridgeline (BLIN) Strengthens Portfolio With HawkSearch Launch
by Zacks Equity Research
Bridgeline's (BLIN) HawkSearch AI unveils Smart Search, transforming e-commerce with advanced AI for precise, image-enhanced searches.
CRMNegative Net Change CAMTNegative Net Change BLINNegative Net Change
artificial-intelligence tech-stocks
Should You Buy Simmons First National (SFNC) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
SFNCNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
AbbVie (ABBV) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
ABBVNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Generative AI Reshapes Healthcare: 3 Stocks in Limelight
by Zacks Equity Research
Stocks like Medtronic (MDT), Stryker (SYK) and NVIDIA (NVDA) are likely to benefit from the rising prospects of Generative AI in healthcare.
MDTPositive Net Change SYKNegative Net Change NVDANegative Net Change HOLXNegative Net Change
artificial-intelligence medical medical-devices
Alphabet (GOOGL) to Boost Bard Capabilities With New Updates
by Zacks Equity Research
Alphabet (GOOGL) is set to launch an array of new feature updates for Google Bard, bolstering its chatbot capabilities.
AMZNPositive Net Change MSFTNegative Net Change BIDUPositive Net Change GOOGLNegative Net Change
artificial-intelligence tech-stocks
Praxis Precision Medicines, Inc. (PRAX) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
PRAXPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Academy Sports and Outdoors, Inc. (ASO) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
ASONegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy Dutch Bros (BROS) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
BROSNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Cerence (CRNC) Benefits From Expanding Clientele, Partner Base
by Zacks Equity Research
Cerence (CRNC) and Microsoft join forces, enhancing in-car experiences with Cerence Assistant and ChatGPT on Microsoft Azure.
MSFTNegative Net Change NVDANegative Net Change CAMTNegative Net Change CRNCPositive Net Change
artificial-intelligence tech-stocks
SentinelOne (S) Enhances Portfolio With PingSafe Acquisition
by Zacks Equity Research
SentinelOne (S) boosts cloud security with the PingSafe acquisition, offering unified protection and advanced CNAPP solutions for a resilient cybersecurity future.
CBNegative Net Change SNegative Net Change NOWNegative Net Change SCWXPositive Net Change
artificial-intelligence cloud-computing tech-stocks
Juniper (JNPR) Boosts Wireless Network Connectivity in Taiwan
by Zacks Equity Research
National Chi Nan University selects Juniper's (JNPR) AI-driven wireless solution to establish a robust digital infrastructure on its campus.
NVDANegative Net Change WDAYNegative Net Change
artificial-intelligence communications tech-stocks
5 Power-Packed ETFs to Buy for 2024
by Sweta Killa
We have highlighted a pack of ETFs that are poised to outperform in 2024.
XLFNegative Net Change DIANegative Net Change ITBNegative Net Change IWFNegative Net Change THNQPositive Net Change
artificial-intelligence etfs finance home-builder
First Horizon National (FHN) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
FHNNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Intel (INTC) to Spin Out AI-Based Software Firm Articul8
by Zacks Equity Research
With Articul8, Intel (INTC) aims to develop a scalable and easy-to-deploy GenAI software platform that will unlock value from client's proprietary data.
INTCPositive Net Change WDAYNegative Net Change DBRGNegative Net Change
artificial-intelligence computers tech-stocks